Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01092182 |
|---|---|
| Brief Title: | Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma |
| First Submitted : | March 23, 2010 |
| First Submitted that Met QC Criteria : | March 23, 2010 |
| First Posted : | March 24, 2010 (Estimate) |
| Results First Submitted : | September 29, 2021 |
| Results First Submitted that Met QC Criteria : | September 29, 2021 |
| Results First Posted : | October 19, 2021 |
| Last Update Submitted that Met QC Criteria : | November 7, 2022 |
| Last Update Posted : | November 9, 2022 |